Hamilton ETFs Announces January 2025 Cash Distributions

Go back to Hamilton ETFs Announces January 2025 Cash Distributions

Mizuho Reiterates Outperform Rating on HCA Healthcare Inc (HCA)

January 27, 2025 11:46 AM EST

Mizuho analyst Ann Hynes reiterated an Outperform rating and $425.00 price target on HCA Healthcare Inc (NYSE: HCA).

The analyst comments "We are maintaining our price target of $425, and our 2025E-2026E adjusted EBITDA estimates, while increasing our 2025E-2026E adjusted EPS estimates driven by... More

HCA Healthcare Inc (HCA) PT Lowered to $404 at Leerink Partners

January 27, 2025 6:23 AM EST

Leerink Partners analyst Whit Mayo lowered the price target on HCA Healthcare Inc (NYSE: HCA) to $404.00 (from $460.00) while maintaining a Outperform rating.

The analyst comments "Bottom Line: Reiterate Outperform rating. 4Q24 results brought forth a continuation of strong demand trends, good cost controls and... More